Echogenicity of basal ganglia structures in different Huntington's disease phenotypes

Carsten Saft1, Rainer Hoffmann, Katrin Strassburger-Krogias

  • 1Department of Neurology, Huntington Centre NRW, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany, carsten.saft@ruhr-uni-bochum.de.

Insights

In Huntington

Area of Science:

  • Neuroimaging
  • Neurology
  • Genetics

Background:

  • Huntington's disease (HD) is an inherited neurodegenerative disorder.
  • Movement disturbances in HD include chorea, bradykinesia, and dystonia.
  • Basal ganglia structure echogenicity may offer insights into HD phenotypes.

Purpose of the Study:

  • To investigate alterations in basal ganglia echogenicity across different Huntington's disease motor phenotypes.
  • To compare transcranial sonography findings in juvenile versus adult-onset HD.

Main Methods:

  • 47 genetically confirmed Huntington's disease patients were classified into choreatic, mixed, or bradykinetic-rigid phenotypes.
  • Neurological examinations and Unified Huntington's Disease Rating Scale subscores were used for classification.
  • Transcranial sonography was performed by blinded investigators.

Main Results:

  • No significant differences in basal ganglia echogenicity were found between the three motor phenotypes.
  • Substantia nigra (SN) echogenicity size correlated with CAG repeat number, bradykinesia, age of onset, and chorea.
  • SN hyperechogenicity was significantly more frequent in juvenile HD (100%) compared to adult HD (29.3%).

Conclusions:

  • Basal ganglia echogenicity does not differ significantly between Huntington's disease motor phenotypes.
  • Juvenile Huntington's disease exhibits marked substantia nigra hyperechogenicity.
  • Transcranial sonography may help differentiate juvenile Huntington's disease.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
11
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
6
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
2
Genetic Lingo01:11

Genetic Lingo

Overview
119.2K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.2K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
5